304 related articles for article (PubMed ID: 24016543)
1. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
2. [Study on C-reactive protein and the risk factors of traditional coronary heart disease].
Guo ZR; Hu XS; Chen FM; Wu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1064-8. PubMed ID: 18396656
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
5. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
7. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
[TBL] [Abstract][Full Text] [Related]
8. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D; Koenig W; Brenner H
Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
[TBL] [Abstract][Full Text] [Related]
10. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population.
Jiang S; Bao Y; Hou X; Fang Q; Wang C; Pan J; Zuo Y; Zhong W; Xiang K; Jia W
Am J Cardiol; 2009 Jun; 103(12):1727-31. PubMed ID: 19539083
[TBL] [Abstract][Full Text] [Related]
11. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
12. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
13. Elevated red blood cell distribution width predicts mortality in persons with known stroke.
Ani C; Ovbiagele B
J Neurol Sci; 2009 Feb; 277(1-2):103-8. PubMed ID: 19028393
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
17. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
[TBL] [Abstract][Full Text] [Related]
18. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
[TBL] [Abstract][Full Text] [Related]
19. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
Kuller LH; Grandits G; Cohen JD; Neaton JD; Prineas R;
Atherosclerosis; 2007 Nov; 195(1):122-8. PubMed ID: 17011566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
